Table 2 Factors associated with immunological status of HIV-infected adults on HAART at the University of Gondar specialized referral hospital

Baseline BMI (kg/m²)

< 18.5

65 (46.8)

74 (53.2)

1.00

-

≥ 18.5

106 (57.6)

78 (42.4)

1.55 (0.99, 2.41)

-

Baseline WHO stage

Stages I & II

57 (64.8)

31 (35.2)

2.42 (1.16, 5.07)

-

Stage III

95 (49.7)

96 (50.3)

1.30(0.67, 2.52)

-

Stage IV

19 (43.2)

25 (56.8)

1.00

-

Duration since ART initiation (year)

1–5

48 (49.5)

49 (50.5)

1.05 (0.55, 2.00)

-

6–10

78 (51.7)

73 (48.3)

0.68 (0.54, 1.12)

-

> 10

45 (60)

30 (40)

1.00

-

Baseline CD4 count

(cell/mm³)

< 200

69 (39.2)

107 (60.8)

1.00

1.00

200–499

70 (63.1)

41 (36.9)

2.65 (1.62, 4.32)

2.7 (1.58, 4.62)*

> 499

32 (88.9)

4 (11.1)

12.61 (4.20, 36.63)

9.59 (3.06, 30.07)*

Patient address

Urban

139 (56.3)

108 (43.7)

1.77 (1.05, 2.98)

1.90 (1.05, 3.43)*

Rural

32 (42.1)

44 (57.9)

1.00

1.00

Current age (year)

≤ 30

39 (66.1)

20 (33.9)

2.04 (1.04, 4.01)

-

31–45

87 (50.6)

85 (49.4)

1.07 (0.64, 1.77)

-

> 45

45 (48.9)

47 (51.1)

1.00

-

Age at enrollment (year)

≤ 25

52 (64.2)

29 (35.8)

1.30 (0.65, 2.61)

0.59 (0.17, 2.10)

26–40

86 (46.5)

99 (53.5)

0.63 (0.35, 1.15)

0.53 (0.15, 0.83)*

> 40

33 (57.9)

24 (42.1)

1.00

1.00